You have 9 free searches left this month | for more free features.

ly2523355

Showing 1 - 7 of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Breast Cancer Trial in United States (LY2523355, ixabepilone, pegfilgrastim)

Completed
  • Metastatic Breast Cancer
  • LY2523355
  • +3 more
  • Fort Myers, Florida
  • +11 more
Sep 9, 2019

Acute Leukemia Trial in United States (LY2523355)

Terminated
  • Acute Leukemia
  • LY2523355
  • Chicago, Illinois
  • +4 more
May 10, 2019

Advanced Cancer, Metastatic Cancer Trial in Albuquerque, Philadelphia (LY2523355, pegfilgrastim)

Completed
  • Advanced Cancer
  • Metastatic Cancer
  • Albuquerque, New Mexico
  • +1 more
Aug 3, 2018

Small Cell Lung Cancer Trial in Korea, Republic of, Romania, United States (LY2523355, Granulocyte colony-stimulating factor

Completed
  • Small Cell Lung Cancer
  • LY2523355
  • Granulocyte colony-stimulating factor (G-CSF)
  • Torrington, Connecticut
  • +10 more
Sep 9, 2019

Advanced Cancer Trial in Nashville, San Antonio (pegfilgrastim, LY2523355)

Completed
  • Advanced Cancer
  • Nashville, Tennessee
  • +1 more
Aug 3, 2018

Solid Tumors Trial in Tokyo (LY2523355)

Completed
  • Solid Tumors
  • LY2523355
  • Tokyo, Japan
    (unnamed)
Jan 25, 2013